Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term: notification
2008
PHARMAC documents that matched your search:
Changes to prescriber restrictions for acitretin and isotretinoin
(4 pages, 190 KB)
2008/12/19
19 December 2008 Changes to prescriber restrictions for acitretin and isotretinoin approved PHARMAC is pleased to announce changes to the prescribing restrictions applying to acitretin and isotretinoin. The changes mean that vocationally registered dermatologists, vocationally registered general practitioners, and nurse…
Clinical advice for switching diltiazem patients
(3 pages, 105 KB)
2008/12/19
Dear Health Professional Changes to the available preparations of diltiazem hydrochloride As a result of concerns about diltiazem hydrochloride prescribing and dispensing errors, some preparations will be delisted from the Pharmaceutical Schedule from 1 June 2009 as follows: Preparations that…
December 2008 Tender results
(3 pages, 144 KB)
2008/12/19
FAX Tender Results To: From: Date: All Suppliers and Wholesalers Yvonne Chen 19 December 2008 No of Pages (including this one): 3 Dear Supplier/Wholesaler TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept a…
Diltiazem notification letter
(4 pages, 38 KB)
2008/12/17
17 December 2008. Changes to the available preparations of Diltiazem Hydrochloride We would like to announce the following changes (effective 1 June 2009) to the preparations of diltiazem hydrochloride that will be available: Preparations that will be delisted Dilzem SR…
2008-11-18 - Full subsidy for erythropoietin beta (Recormon) notification
(3 pages, 160 KB)
2008/11/18
18 November 2008 Full subsidy for erythropoietin beta (Recormon) will continue PHARMAC is pleased to announce the approval of a supply agreement with Roche which includes the following components: · · · A price/subsidy reduction for erythropoietin beta (Recormon). An…
2008-11-18 - Funding of a new brand of adrenaline (1:1000) injection notification
(1 page, 35 KB)
2008/11/18
18 November 2008 Funding of a new brand of adrenaline (1:1000) injection Proposal summary PHARMAC is pleased to announce the approval of the funding of Aspen Pharmacare Australia Pty Limited’s brand of adrenaline 1 in 1,000, 1 ml solution for…
Fluorouracil sodium 5% cream (Efudix) funding proposal
(1 page, 138 KB)
2008/11/10
7 November 2008 Fluorouracil sodium 5% cream (Efudix) funding proposal approved PHARMAC is pleased to announce the approval of a supply agreement with Pacific Pharmaceuticals Ltd for fluorouracil sodium 5% cream (Efudix). Efudix is used as a topical treatment for…
Notification - funding of a new brand of anastrozole
(2 pages, 149 KB)
2008/11/06
6 November 2008 Funding of a new brand of anastrozole We are pleased to advise that the PHARMAC Board has approved the proposal to fund Douglas Pharmaceuticals’ brand of the aromatase inhibitor anastrozole and amend the Special Authority criteria applying…
Notification: Funding approved for new antipsychotic treatment
(2 pages, 125 KB)
2008/11/05
5 November 2008 Funding approved for new antipsychotic treatment PHARMAC is pleased to announce the approval of funding for a new antipsychotic treatment, amisulpride (Solian), from 1 December 2008, under an agreement with Sanofi-Aventis. Amisulpride will be funded without the…
23-10-2008 - Notification of Goldshield Levothyroxine subsidisation
(1 page, 103 KB)
2008/10/23
23 October 2008 Goldshield levothyroxine subsidised from 1 November 2008 PHARMAC is pleased to announce that the Goldshield brand of levothyroxine will be fully subsidised from 1 November 2008. Details of the decision From 1 November 2008, the Goldshield brand…
